Metformin increases the uptake of glucose into the gut from the circulation in high-fat diet-fed male mice, which is enhanced by a reduction in whole-body Slc2a2 expression
Objectives: Metformin is the first line therapy recommended for type 2 diabetes. However, the precise mechanism of action remains unclear and up to a quarter of patients show some degree of intolerance to the drug, with a similar number showing poor response to treatment, limiting its effectiveness....
Main Authors: | Nicola Morrice, Susanne Vainio, Kirsi Mikkola, Lidy van Aalten, Jennifer R. Gallagher, Michael L.J. Ashford, Alison D. McNeilly, Rory J. McCrimmon, Alexandra Grosfeld, Patricia Serradas, Jukka Koffert, Ewan R. Pearson, Pirjo Nuutila, Calum Sutherland |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-11-01
|
Series: | Molecular Metabolism |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212877823001412 |
Similar Items
-
Central deficiency of IL-6Ra in mice impairs glucose-stimulated insulin secretion
by: Alison D. McNeilly, et al.
Published: (2022-07-01) -
Five Novel Mutations in Cystinuria Genes SLC3A1 and SLC7A9
by: Popovska-Jankovic K, et al.
Published: (2009-01-01) -
Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer
by: Lutfi H. Alfarsi, et al.
Published: (2020-02-01) -
Impact of Placental SLC2A3 Deficiency during the First-Half of Gestation
by: Cameron S. Lynch, et al.
Published: (2022-10-01) -
Structural and functional implications of SLC13A3 and SLC9A6 mutations: an in silico approach to understanding intellectual disability
by: Syeda Iqra Hussain, et al.
Published: (2023-10-01)